5DVA
Fragments bound to the OXA-48 beta-lactamase: Compound 1
5DVA の概要
エントリーDOI | 10.2210/pdb5dva/pdb |
関連するPDBエントリー | 4s2p |
分子名称 | Beta-lactamase, 3-(pyridin-4-yl)benzoic acid, CHLORIDE ION, ... (4 entities in total) |
機能のキーワード | hydrolase, inhibitor, complex, fragment, lactamase |
由来する生物種 | Klebsiella pneumoniae |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 114059.84 |
構造登録者 | |
主引用文献 | Lund, B.A.,Christopeit, T.,Guttormsen, Y.,Bayer, A.,Leiros, H.K. Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening. J.Med.Chem., 59:5542-5554, 2016 Cited by PubMed Abstract: The spread of antibiotic resistant bacteria is a global threat that shakes the foundations of modern healthcare. β-Lactamases are enzymes that confer resistance to β-lactam antibiotics in bacteria, and there is a critical need for new inhibitors of these enzymes for combination therapy together with an antibiotic. With this in mind, we have screened a library of 490 fragments to identify starting points for the development of new inhibitors of the class D β-lactamase oxacillinase-48 (OXA-48) through surface plasmon resonance (SPR), dose-rate inhibition assays, and X-ray crystallography. Furthermore, we have uncovered structure-activity relationships and used alternate conformations from a crystallographic structure to grow a fragment into a more potent compound with a KD of 50 μM and an IC50 of 18 μM. PubMed: 27165692DOI: 10.1021/acs.jmedchem.6b00660 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.50003891197 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード